Organisation/s:
Monash University, The University of Sydney, The University of Melbourne, The University of Newcastle, The University of New South Wales
Funder:
Dr Shipley reported receiving a Research Training Programstipend scholarship at
Monash University from the Australian government during the conduct of the study.Dr Beadnall reported receiving
educational travel support from Merck and Novartis and personal fees from Roche,Novartis, and Biogen outside the
submittedwork. Dr Yeh reported receiving personal fees from Merck and Novartis; travel support from UCB; and
research support from the European Committee for Treatment and Research in Multiple Sclerosis and RACP Foundation
outside the submittedwork. Dr Horakova reported receiving grants from First Faculty of Medicine Charles University
and General University Hospital in Prague during the conduct of the study and personal fees from Merck, Sanofi,
Roche, and Biogen outside the submittedwork. Prof Havrdova reported receiving personal fees from Sanofi AB,
Roche, Johnson&Johnson AB, Merck AB, and Novartis outside the submittedwork. Prof Kalincik reported receiving
personal fees fromMSInternational Federation andWorld Health Organization, Therapeutic Goods Administration,
BMS, Roche, Janssen, Genzyme,Novartis, Merck, and Biogen; conference travel support and/or speaker honoraria
fromWebMD Global, Merck, Sandoz, Novartis, Biogen, Roche, Eisai, Genzyme, Teva, and BioCSL; and research or
educational event support from Biogen, Novartis, Genzyme, Roche, Celgene, and Merck outside the submittedwork.
Dr Roos reported receiving grants from National Health and Medical Research Council (NHMRC) and personal fees
from Merck, Novartis, and Roche outside the submittedwork. Prof Lechner-Scott reported receiving grants from
Merck, personal fees from Merck, and personal fees from Novartis outside the submittedwork. Dr Alroughani reported
receiving personal fees from Roche,Novartis, AstraZeneca, Merck, Biogen, and Sanofi outside the submitted
work. Dr Peterka reported receiving personal fees from Merck, Novartis, Biogen, Sanofi-Genzyme, Janssen-Cilag,
Teva, Roche, and Bristol-Myers Squibb.Dr Buzzard reported receiving personal fees from Biogen, Roche, Merck, Sanofi,
and Novartis during the conduct of the study and personal fees from Alexion, UCB, and Argenx outside the submittedwork.
Dr Maimone reported receiving personal fees from Biogen, Merck, Novartis, Roche, Sanofi, and Alexion
outside the submittedwork. Dr Foschi reported receiving personal fees from Roche,Novartis, Merck, Sanofi, Biogen,
and Bristol-Myers Squibb during the conduct of the study.Dr Lugaresi reported receiving grants from Novartis and
Roche and personal fees from Alexion,Amgen/Horizon, Biogen, Bristol-Myers Squibb/Celgene, Merck Serono,Novartis,
Roche, Sanofi/Genzyme, and Janssen/Johnson&Johnson outside the submittedwork. Prof Tomassini reported
receiving personal fees from Roche,Novartis, Viatris,Amgen, Merck, Bristol-Myers Squibb, Janssen, Alexion, Horizon,
and Biogen outside the submittedwork. Dr John reported being a PI onMS commercial studies sponsored by
Roche,Novartis, Sanofi-Genzyme, and Biogen and receiving personal fees from Merck and Novartis outside the submittedwork.
Dr Meca-Lallana reported receiving personal fees from Almirrall, Biogen, Neuraxpharm, and Sandoz;
grants from Biogen and UCB; nonfinancial support, personal fees, and grants from Bristol-Myers Squibb, Merck,
Novartis, Roche, and Sanofi; and nonfinancial support and personal fees from Johnson&Johnson outside the submittedwork.
Prof Butzkueven reported receiving support to institution from Roche and Merck; service agreement
fees to institution from Novartis, Merck, Biogen, and UCB; travel support from Novartis and Merck; and personal fees
from Merck, Novartis, and Roche outside the submittedwork. Dr Van derWalt reported receiving personal fees from
Novartis, Roche, and Merck; grants, travel support, and personal fees fromMSAustralia; grants from NHMRC; and
personal fees as Chief Operating Officer from MSBase Foundation outside the submittedwork. Dr Jokubaitis reported
receiving grants from NHMRC,MSAustralia, Australian Medical Research Future Fund, F. Hoffman La-Roche,
and Pennycook Foundation and personal fees from Novartis outside the submittedwork. No other disclosures
were reported.
Sign In
Australia; VIC
